Table 1.
Baseline and demographic data of the patient cohort.
| Variable | Cohort (n = 12) |
|---|---|
|
Age (n, median, IQR)
Gender (n, %) Male Female |
68.5 (62–72) 6 (50%) 6 (50%) |
| BMI (kg/m2, median, IQR) | 27.3 (26.40–28.20) |
|
ASA score (n, %)
I II III IV |
2 (16.7%) 10 (83.30%) 0 (0%) 0 (0%) |
| Charlson Comorbidity Index (median, IQR) | 4 (4–5) |
| Diabetes (n, %) | 2 (16.70%) |
| Hypertension (n, %) | 6 (50%) |
| Preoperative Hemoglobin (g/dL, median, IQR) | 13.6 (13–14.70) |
| Preoperative Creatinine (mg/dL, median, IQR) | 0.98 (0.81–1.17) |
| Preoperative eGFR (mL/min/1.73 m2, median, IQR) | 69.5 (47.50–74.30) |
| Clinical Tumor Size (mm, median, IQR) | 47.5 (34–55) |
|
cT (n, %)
T1a T1b T2a |
4 (33.30%) 6 (50%) 2 (16.70%) |
|
Side (n, %)
Right Left |
6 (50%) 6 (50%) |
| R.E.N.A.L. score (median, IQR) | 7 (5–9) |
BMI: body mass index; ASA: American Society of Anesthesiologists; eGFR: estimated glomerular filtration rate.